C07K 2317/31
Multispecific
Official title: multispecific
C07K2317/31 (Multispecific) appears on 4,372 US grants and 9,748 published applications in this corpus.
Search patents in C07K- Granted patents
- 4,372
- Published applications
- 9,748
- Assignees
- 2,026
- Inventors
- 13,632
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 7 | 0 |
| 1998 | 6 | 0 |
| 1999 | 12 | 0 |
| 2000 | 20 | 0 |
| 2001 | 11 | 8 |
| 2002 | 12 | 24 |
| 2003 | 8 | 34 |
| 2004 | 12 | 39 |
| 2005 | 6 | 40 |
| 2006 | 14 | 52 |
| 2007 | 10 | 50 |
| 2008 | 18 | 50 |
| 2009 | 30 | 84 |
| 2010 | 29 | 110 |
| 2011 | 45 | 138 |
| 2012 | 57 | 124 |
| 2013 | 72 | 210 |
| 2014 | 107 | 275 |
| 2015 | 152 | 318 |
| 2016 | 187 | 420 |
| 2017 | 246 | 492 |
| 2018 | 282 | 501 |
| 2019 | 260 | 537 |
| 2020 | 310 | 678 |
| 2021 | 386 | 789 |
| 2022 | 378 | 918 |
| 2023 | 376 | 936 |
| 2024 | 468 | 1151 |
| 2025 | 496 | 953 |
| 2026 | 354 | 817 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bispecific chimeric antigen receptors targeting CD20 and BCMA6 Oct 2026US 12,751,973 B2Abelzeta Inc.
- Aggrecan binding immunoglobulins6 Oct 2026US 12,753,224 B2Ablynx N. V.
- Anti-MS4A4A antibodies and methods of use thereof6 Oct 2026US 12,753,225 B2Alector LLC
- Antibodies against human TSLP and use thereof6 Oct 2026US 12,753,227 B2Beijing Wisdomab Biotechnology Co., Ltd
- Anti-Nectin-4 antibody, conjugate including the same, and application thereof6 Oct 2026US 12,753,230 B2Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
- Anti-cmet antibody, antibody-drug conjugate, and preparation method therefor and use thereof8 Oct 2026US 2026/0306651 A1MediLink Therapeutics (Suzhou) Co., Ltd.
- Radiolabeled met binding proteins for immuno-pet imaging8 Oct 2026US 2026/0306682 A1Regeneron Pharmaceuticals, Inc.
- Multi-receptor natural killer cells8 Oct 2026US 2026/0308225 A1Board of Regents, The University of Texas System
- Compostions of multispecific antigen binding polypeptides and methods of use8 Oct 2026US 2026/0308242 A1Revopsis Therapeutics, Inc.
Most cited
By later US patents
- Immunoglobulin variants1,380US 5,821,337 AGenentech, Inc. · 1998
- Humanized antibodies and methods for making them1,003US 6,054,297 AGenentech, Inc. · 2000
- Method for making humanized antibodies943US 6,407,213 B1Genentech, Inc. · 2002
- Low pH hydrophobic interaction chromatography for antibody purification599US 5,641,870 AGenentech, Inc. · 1997
- Dual variable domain immunoglobulin and uses thereof391US 7,612,181 B2Abbott Laboratories · 2009